RxDoctor Payments DataLook up a doctor →

Eric Carbonell

Psychiatry · Festus, MONPI 1801805791

Payments from drug & device makers

$5,359,514in general payments, 2019–2025

Across 511 payments — averaging $10,488 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sage Therapeutics, LLC$2.2M
  • Axsome Therapeutics, Inc.$1.1M
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$973K
  • Janssen Research & Development, LLC$330K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$262K
  • AbbVie$257K
  • plus $248K from 9 others

General payments by program year

20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sage Therapeutics, LLC116$2,187,181
Axsome Therapeutics, Inc.25$1,102,942
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)242$972,759
Janssen Research & Development, LLC40$330,159
Otsuka Pharmaceutical Development & Commercialization, Inc.14$261,897
AbbVie(2 entities)25$256,866
E.r. Squibb & Sons, L.L.C.15$193,641
Boehringer Ingelheim6$24,197
Novo Nordisk AS15$14,828
Teva Pharmaceuticals USA, Inc.5$6,750
Eli Lilly3$6,170
Biohaven Pharmaceutical Holding Company Ltd.2$2,000
Boehringer Ingelheim International GmbH1$83
Johnson & Johnson1$25
Sunovion Pharmaceuticals Inc.1$16

How this compares

$5,359,514 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri →

Other psychiatry in Festus

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →